DexCom, Inc

DC4 XETRA / Francfort Healthcare & Biotech United States
62.80

DexCom develops, manufactures and distributes continuous glucose monitoring systems primarily for diabetic patients.

Performance & Momentum

6 Months 10.12 %
1 Year 16.10 %
3 Years 46.46 %
5 Years 23.65 %

Similar stocks to DexCom, Inc

Anantys Community

Be the first to share your analysis on DexCom, Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases